Erste Asset Management GmbH »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Erste Asset Management GmbH

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Erste Asset Management GmbH from 13F filings

Historical chart of Erste Asset Management GmbH investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Erste Asset Management GmbH consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Erste Asset Management GmbH

Quarter filed Position value Share count Share price at filing
2025-09-30 $0 0 0.00
2025-06-30 $1.8M 1.4M 1.29
2025-03-31 $0 0 0.00

More positions owned by Erste Asset Management GmbH

Nvidia Corporation Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Progressive Corp Common Stock (PGR)
Visa Common Stock (V)
Abbott Labs Common Stock (ABT)
Netflix Common Stock (NFLX)
Ishares Gold Tr Fund/ETF (IAU)
Booking Holdings Common Stock (BKNG)
Lam Research Corp Common Stock (LRCX)
Jpmorgan Chase & Co. Common Stock (JPM)

View all positions for Erste Asset Management GmbH

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Manufacturers Life Insurance Company
FMR
LMR Partners
MacKay Shields
Parallax Volatility Advisers
BlackRock
Lord, Abbett & Co
Universal- Beteiligungs- und Servicegesellschaft mbH
SSI Investment Management
Jpmorgan Chase & Co
Nicholas Investments Partners
State of Wisconsin Investment Board

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1